Improvement in Cutaneous Lupus Erythematosus After 20 Weeks of Belimumab Use - A Systematic Review and Meta-Analysis.
Rachel KneelandDaniel MontesJustin EndoBridget ShieldsChristie M BartelsShivani GargPublished in: Arthritis care & research (2022)
Findings support belimumab as an effective therapy for CLE with SLE. Likewise, they inform patient counseling regarding estimates of 20 weeks to achieve response.